| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006821216 |
| P356 | DOI | 10.1054/BJOC.2001.2054 |
| P932 | PMC publication ID | 2375159 |
| P698 | PubMed publication ID | 11710818 |
| P5875 | ResearchGate publication ID | 11644024 |
| P50 | author | Fiona Blackhall | Q37831554 |
| Gordon C. Jayson | Q37839060 | ||
| Catherine L Merry | Q58858171 | ||
| P2093 | author name string | Davies EJ | |
| P2860 | cites work | Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 |
| EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis | Q22254463 | ||
| Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member | Q24290385 | ||
| Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome | Q24320198 | ||
| The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate | Q24323532 | ||
| The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer | Q24564355 | ||
| Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo | Q24564477 | ||
| Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA | Q24646731 | ||
| Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene | Q28144537 | ||
| Regulated Diversity of Heparan Sulfate | Q28282444 | ||
| The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan Sulfate | Q28284035 | ||
| glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development | Q28507693 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity | Q32030968 | ||
| Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney | Q32064386 | ||
| Hereditary multiple exostoses. | Q33596753 | ||
| Frequent silencing of the GPC3 gene in ovarian cancer cell lines | Q33852778 | ||
| Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma | Q33888628 | ||
| Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics | Q33899439 | ||
| Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. | Q35644251 | ||
| OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. | Q36255453 | ||
| Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. | Q42125042 | ||
| Highly sensitive sequencing of the sulfated domains of heparan sulfate. | Q42814375 | ||
| Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro | Q53437765 | ||
| Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers | Q57767952 | ||
| EXTL3/EXTR1 alterations in colorectal cancer cell lines | Q73118804 | ||
| Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ | Q73337621 | ||
| Serum syndecan-1: a new independent prognostic marker in multiple myeloma | Q73337882 | ||
| Heparan sulfate proteoglycan expression in human lung-cancer cells | Q73507963 | ||
| Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential | Q73841954 | ||
| Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas | Q73870254 | ||
| Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice | Q73977149 | ||
| Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation | Q74412811 | ||
| Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome | Q77349750 | ||
| Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma | Q78227067 | ||
| ??? | Q22009535 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer | Q12078 |
| carbohydrate | Q11358 | ||
| heparan sulfate proteoglycans | Q66589633 | ||
| heparitin sulfate | Q76876869 | ||
| P304 | page(s) | 1094-1098 | |
| P577 | publication date | 2001-10-01 | |
| 2001-10-19 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Heparan sulfate proteoglycans and cancer | |
| P478 | volume | 85 |
| Q98195609 | 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma |
| Q35683181 | A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis |
| Q35823840 | A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology? |
| Q38972454 | A combinatorial approach to biophysically characterise chemokine-glycan binding affinities for drug development |
| Q36158701 | A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer. |
| Q64377517 | A novel system to study adenovirus tropism to normal and malignant colon tissues |
| Q34262594 | A sharp end to sugary Wingless travels |
| Q27983051 | Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activity |
| Q42259794 | Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells |
| Q43752663 | Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population. |
| Q38235405 | Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surface |
| Q34664372 | Chondrodysplasias due to proteoglycan defects |
| Q35769319 | Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation |
| Q38936327 | Convergent evolution of defensin sequence, structure and function |
| Q24683229 | Current developments in adenovirus-based cancer gene therapy |
| Q36011762 | Cytokines and growth factors cross-link heparan sulfate |
| Q35108319 | D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. |
| Q42643458 | Distinct tissue-specificity of three zebrafish ext1 genes encoding proteoglycan modifying enzymes and their relationship to somitic Sonic hedgehog signaling |
| Q39411671 | Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers |
| Q36906823 | Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate |
| Q34199179 | Expression of glypican 3 in placental site trophoblastic tumor |
| Q37536514 | Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck |
| Q41786499 | GPC5 Gene and Its Related Pathways in Lung Cancer |
| Q24673634 | Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2 |
| Q36119681 | Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis |
| Q40063020 | Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy |
| Q28383607 | Genetic variants and risk of lung cancer in never smokers: a genome-wide association study |
| Q28218950 | GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism |
| Q36361216 | Glycosaminoglycans are involved in bacterial adherence to lung cells. |
| Q37351931 | Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis |
| Q28285447 | Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma |
| Q90354201 | Heparan Sulfate Proteoglycans in Human Colorectal Cancer |
| Q24653774 | Heparan sulphate synthetic and editing enzymes in ovarian cancer |
| Q38004630 | Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands. |
| Q36738310 | Human β-defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation. |
| Q33234482 | Identification of candidates for tumor-specific alternative splicing in the thyroid. |
| Q26822264 | Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer |
| Q28386853 | Lung cancer in never smokers |
| Q34362241 | Lung cancer in never smokers: Disease characteristics and risk factors |
| Q92761481 | MetaOmGraph: a workbench for interactive exploratory data analysis of large expression datasets |
| Q42464523 | Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer |
| Q21284215 | Minimus: a fast, lightweight genome assembler |
| Q35423844 | Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase. |
| Q34935175 | N,N,N-Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells |
| Q64063119 | NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans |
| Q36486204 | Natural killer cells in non-hematopoietic malignancies |
| Q34256752 | Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB |
| Q89757731 | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
| Q35088166 | Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma |
| Q38181492 | Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer |
| Q44785625 | Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy |
| Q38869849 | Probing glycosaminoglycan spectral signatures in live cells and their conditioned media by Raman microspectroscopy. |
| Q36769318 | Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer |
| Q53607385 | Proteoglycan mechanics studied by single-molecule force spectroscopy of allotypic cell adhesion glycans |
| Q35932893 | Proteoglycans in brain development |
| Q47667044 | Proteoglycans in the control of tumor growth and metastasis formation. |
| Q33803148 | Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer |
| Q35041008 | ROS-DET: robust detector of switching mechanisms in gene expression |
| Q34718195 | Roles of heparan-sulphate glycosaminoglycans in cancer |
| Q35061390 | SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway |
| Q60960526 | Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas |
| Q37772524 | Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate |
| Q59813042 | Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development |
| Q73158118 | Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica |
| Q35441324 | Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma |
| Q37008599 | Syndecan-1: a dynamic regulator of the myeloma microenvironment |
| Q35548533 | Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells |
| Q36169514 | Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology. |
| Q39399937 | Targeting heparin and heparan sulfate protein interactions. |
| Q38319148 | Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation |
| Q33361929 | The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle |
| Q36065054 | The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice. |
| Q64120685 | The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis |
| Q34774487 | The other side of TGF-beta superfamily signal regulation: thinking outside the cell. |
| Q89736315 | Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function |
| Q55518010 | Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. |
Search more.